Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 15 - Caught on Camera

'Clinical trials on computers cut costs and reduce need for human volunteers'

Miriam Stoppard discusses the rising use of computer simulations in clinical trials which drastically cuts costs and reduces the need to use humans or animals

Daily Mirror

Small Pharma's Q2 2023 Financial Results, 'Ultra Short-Acting Psychedelic Program' Underway

Small Pharma Inc. (OTCQB: DMTTF), a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six months ended August 31, 2022. For the period numbers show:

Benzinga

The miracle tablet that has kept a beloved granddad's deadly prostate cancer at bay for a DECADE

A biopsy showed Jim had stage 4 - the most advanced stage - prostate cancer. It had spread to the lymph nodes and wasn’t curable, but then Jim was placed on an experimental trial

Manchester Evening News

From analysis to the latest developments in health,
read the most diverse news in one place.

Coronavirus: India's first antidote against COVID 'VINCOV-19' ready for phase 3 clinical trial

The phase 3 clinical trial of the first antidote against COVID, VINCOV-19, is expected to begin soon as the drug is ready for market authorization. VINCOV-19 is a joint effort of the University of Hyderabad (UoH), the Centre for Cellular and Molecular Biology (CCMB) and VINS Bioproducts Limited.

The Times of India

Three years after clinical trial, ketamine provides hope for severely depressed

LOS ANGELES -- Patients arriving at Dr. Philip O'Carroll's Newport Beach office for their first ketamine treatment are in pain and often lost. They have visited other doctors, tried other solutions and are ready for what is considered a last resort.

Los Angeles Times

Scientists tricked 200 mosquitoes into delivering malaria vaccines to humans

Scientists have turned one of the deadliest insects into a malaria vaccine delivery system. According to new reports from NPR (National Public Radio, US), a small clinical trial of 26 participants has been underway in the United Kingdom, developing a system to use mosquitoes to deliver vaccines. The findings of…

The Times of India

CBD Oil On Behavioral Disturbances In Dementia Patients, Positive Clinical Trial

In a recent study published in Frontiers in Medicine, researchers showed that "almost 90% of patients with dementia suffer from some type of neurobehavioral symptom, and there are no approved medications to addr

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Another prospect for an Alzheimer's drug renews cost concerns

But positive clinical trial results also renew the hopes of millions of seniors.

Axios

‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’

The new clinical trial found that there was a significant reduction in the decline in memory and thinking usually seen in early-stage patients.

The Independent UK

Courageous Lanarkshire teen who survived leukaemia thanks to a clinical trial pursues nursing dream

Katie Currie, 19, who is in remission from the disease, has been chosen to help launch Childhood Cancer Awareness month in Scotland this September.

Daily Record

'I wouldn't be here today if my mum wasn't always looking for new cancer treatments'

Joan McFadden speaks to a mum-daughter duo who have discovered the importance of clinical research trials for those living with cancer. Here, they tell their story

Daily Mirror

Lanarkshire MP backs call to get more participants for dementia clinical trials

New figures reveal significantly fewer people are taking part in dementia research compared to other health conditions.

Daily Record

Canada Studies Effects Of Psilocybin For COVID Frontline Healthcare Workers In Phase 2 Clinical Trial

Alberta-based ATMA Journey Centers Inc.

Benzinga

Heartbreak for a Dinnington family searching for a miracle - as 'warrior' Lucy, 8, suffers with a terminal brain tumour

Lucy Bromley was diagnosed with an incurable brain tumour earlier this year. Her family is trying to raise money to enrol her in an experimental clinical trial.

Chronicle Live

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse

This team of doctors reveals how to avoid a massive pitfall in making new drugs

Identifying and addressing the barriers to enrolling in research that patients face can increase participation and lead to better patient care.

ABC News

Clinical trials that can give cancer patients access to life-saving treatments now offer new hope for rural communities

Stephen Wadey was diagnosed with melanoma seven years ago. After surgery to remove the cancer, he decided to join a clinical trial — despite the huge distance.

Benzinga

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

Benzinga

Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary

Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), the study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Akero Therapeutics shares…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Benzinga

Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay

Key Takeaways: The company logged a revenue fall of 55% in the first half of the year and posted a loss of $131 million Phase 3 clinical trials for its Covid-19 oral drug wrapped up in May but the company has still not yet filed an application to market the…

Benzinga

Anebulo Pharma Posts FY 2022 Earnings, Positive Results From Clinical Trial For Treatment Of Acute Cannabinoid Intoxication

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, released its financial results for the three months and twelve months ended June 30, 2022.

The Conversation

Yes, Black patients do want to help with medical research – here are ways to overcome the barriers that keep clinical trials from recruiting diverse populations

Clinical trial participants are predominantly white. Despite Black and Hispanic people respectively making up 12% and 16% of the U.S. population in 2011, together they made up only 6% of clinical trial participants overall that year.

Wales Online

Woman who was given just months to live is now cancer-free after taking part in clinical trial

Eliana Keeling was reeling after a routine blood test revealed she had a type of blood cancer just a week before Christmas

Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002, for the treatment of hereditary angioedema (HAE). Intellia shares traded in a range of $56.52 to $60.06 on day volume of 901.43 thousand shares, closed regular trading session at $59.97. The company…

Benzinga

Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy

Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University College London

202 stories

Alzheimer Research UK

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.